The Global Market for Human Reproductive Technologies is Projected to Reach US$23.1 Billion by 2020

Advanced ART Methods to Treat Infertility to Drive the Human Reproductive Technologies Market, According to a New Report by Global Industry Analysts, Inc.

GIA launches comprehensive analysis of industry segments, trends, growth drivers, market share, size and demand forecasts on the global Human Reproductive Technologies market. The global market for Human Reproductive Technologies is projected to reach US$23.1 billion by 2020, driven by rising infertility rates due to advancing maternal age among older women, and nutritional deficiencies, lifestyle stress and exposure to toxic environmental agents in younger women.
The Human reproductive technologies market is broadly divided into contraceptive technologies (drugs & devices), and drugs and procedures to treat infertility. Delayed parenthood decisions, rising rates of infertility due to lifestyle factors such as smoking and alcohol abuse, increased patient awareness about newer contraceptive devices and ART methods, growing affluence and adoption of expensive healthcare services, are all expected to boost the global market for human reproductive technologies. Contraceptive technologies are witnessing rapid growth in the market, driven by early onset of sexual activity, social awareness over the importance of preventing unwanted teenage pregnancies, delayed parenthood decisions among the growing base of working women, and the need to prevent STDs. Oral contraceptive pills and male condoms are popular types of contraception, on account of higher patient awareness, and easy availability and access. Hormonal transdermal and subdermal patches, and highly effective intrauterine devices are also gaining in importance. Factors driving the IUD market include high effectiveness and lesser side effects when compared to other means of contraception.
About 10-13% of couples globally have fertility problems. Infertility is primarily addressed by drugs as the first line of treatment, followed by Assisted Reproductive Technology (ART). ART, which uses in-vitro techniques and related methods, represents a thriving market. The market is dominated by In-Vitro Fertilization (IVF), IntraUterine Insemination (IUI), Intra Cytoplasmic Sperm Injection (ICSI), and the rarer techniques of Zygote IntraFallopian Transfer and Gamete IntraFallopian Transfer. IVF remains one of the most popular ART methods. An estimated 1.5 million IVF cycles are performed worldwide every year, of which about 42% of cycles are conducted in Europe. Factors restraining the IVF market include high treatment costs, the need for multiple cycles that adds up to the cost, lower awareness levels in developing economies such as Nigeria, and the risk of multiple pregnancies (twins, triplets & quadruplets). With the use of modern, milder ovulatory drugs and the implantation of only one embryo, the risk of multiple births has declined considerably.

As stated by the new market research report on Human Reproductive Technologies, the United States represents the largest market worldwide. Research and Development of innovative contraceptives, and technological advancements in ART drive the U.S. market. Asia-Pacific ranks as the fastest growing market, with a CAGR of 3.8% over the analysis period. The growth in the region is driven by rising population, increased awareness of contraceptive technologies, and a thriving fertility tourism industry.

Major players covered in the report include Ansell Limited, Agile Therapeutics, Bayer HealthCare, Church & Dwight Co., Inc., Cipla Limited, CellCura ASA, Cook Medical, CooperSurgical, Ferring Pharmaceuticals, Fuji Latex Co., Ltd., Genea Biomedx, Merck KGAA, Okamoto Industries, Pfizer Inc., Progyny, Inc., Reckitt Benckiser Group Plc., Sanofi, Teva Pharmaceutical Industries Ltd., and The Female Health Company, among others.

The research report titled “Human Reproductive Technologies: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of the market trends, market issues, growth drivers, and strategic industry activity of global companies.  The report provides market estimates and projections for major geographic markets, including the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, and Rest of Asia-Pacific), Middle East & Africa, and Latin America (Brazil & Rest of Latin America).


Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.

Comments

Popular posts from this blog

The Global Market for Big Data Technologies and Services is Projected to Reach $60 Billion by 2022

The Global Market for Surfing is Projected to Reach US$9.5 Billion by 2022

The Global Market for Private Tutoring Services is Forecast to Reach US$227 Billion by 2022